| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YEXCR.2009.05.009 |
| P698 | PubMed publication ID | 19460366 |
| P50 | author | Michael Kyba | Q41174593 |
| Zhaohui Xu | Q47502264 | ||
| P2093 | author name string | Kristine E Kamm | |
| Eun Ji Gang | |||
| Radbod Darabi | |||
| Rita C R Perlingeiro | |||
| Darko Bosnakovski | |||
| P2860 | cites work | Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C | Q24554516 |
| A Foxo/Notch pathway controls myogenic differentiation and fiber type specification | Q24678520 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene | Q28139858 | ||
| PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group | Q28201860 | ||
| Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes | Q28209232 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Cell Therapy of -Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts | Q29302095 | ||
| Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors | Q29547596 | ||
| Dystrophin: the protein product of the Duchenne muscular dystrophy locus | Q29618077 | ||
| Marrow stromal cells as stem cells for nonhematopoietic tissues | Q29618770 | ||
| Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals | Q30050310 | ||
| Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation | Q33202256 | ||
| From marrow to brain: expression of neuronal phenotypes in adult mice. | Q33926766 | ||
| Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice | Q34269619 | ||
| Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma | Q34334974 | ||
| Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma | Q34347334 | ||
| A Pax3/Pax7-dependent population of skeletal muscle progenitor cells | Q34412889 | ||
| Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors | Q34441929 | ||
| SSEA-4 identifies mesenchymal stem cells from bone marrow | Q34576375 | ||
| Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas | Q35144171 | ||
| Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle | Q35835194 | ||
| Critical variables in the conversion of marrow cells to skeletal muscle | Q35848052 | ||
| Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration | Q36324366 | ||
| Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse | Q36403623 | ||
| Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles | Q36879972 | ||
| Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. | Q37598848 | ||
| Bone marrow as a potential source of hepatic oval cells | Q38501137 | ||
| Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage | Q39994310 | ||
| SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression | Q40076975 | ||
| Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells | Q40243228 | ||
| The genetic basis of neuromuscular disorders | Q41092673 | ||
| Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. | Q41268880 | ||
| Pax3/Pax7 mark a novel population of primitive myogenic cells during development | Q42863008 | ||
| Cell fusion is the principal source of bone-marrow-derived hepatocytes | Q44383220 | ||
| Bone marrow-derived stem cells initiate pancreatic regeneration. | Q44486484 | ||
| Failure to correct murine muscular dystrophy | Q45878260 | ||
| Muscle regeneration by bone marrow-derived myogenic progenitors | Q45885806 | ||
| Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. | Q46003277 | ||
| Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium | Q46057122 | ||
| A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. | Q46176856 | ||
| Bone marrow stromal cells generate muscle cells and repair muscle degeneration. | Q46588810 | ||
| Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro | Q47593186 | ||
| Failure of bone marrow cells to transdifferentiate into neural cells in vivo | Q48501589 | ||
| Direct isolation of satellite cells for skeletal muscle regeneration. | Q50756094 | ||
| Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. | Q50786793 | ||
| Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube. | Q50926565 | ||
| Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. | Q51210701 | ||
| Functional skeletal muscle regeneration from differentiating embryonic stem cells. | Q51966818 | ||
| HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. | Q52121270 | ||
| Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts | Q59064540 | ||
| Dystrophin expression in the mdx mouse restored by stem cell transplantation | Q59069004 | ||
| Skeletal muscle differentiation potential of human adult bone marrow cells | Q61943953 | ||
| MyoD is required for myogenic stem cell function in adult skeletal muscle | Q71172968 | ||
| Application of bone marrow-derived stem cells in experimental nephrology | Q77149649 | ||
| Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice | Q77378087 | ||
| Myogenic Expression of Mesenchymal Stem Cells within Myotubes of mdx Mice in Vitro and in Vivo | Q84821746 | ||
| P4510 | describes a project that uses | MSCB9-Pax3 | Q54906829 |
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell line | Q21014462 |
| mesenchymal stem cell | Q1922379 | ||
| P304 | page(s) | 2624-2636 | |
| P577 | publication date | 2009-05-19 | |
| P1433 | published in | Experimental Cell Research | Q1524289 |
| P1476 | title | Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery | |
| P478 | volume | 315 |
| Q58999088 | Adipose-Derived Stem Cells in Tissue Regeneration: A Review |
| Q39670600 | Applications of skeletal muscle progenitor cells for neuromuscular diseases |
| Q34344594 | Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF |
| Q34964840 | Coaxing stem cells for skeletal muscle repair |
| Q45045378 | Comparative analysis of reference gene stability in human mesenchymal stromal cells during osteogenic differentiation |
| Q38267714 | Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions |
| Q41387531 | Direct reprogramming of fibroblasts into skeletal muscle progenitor cells by transcription factors enriched in undifferentiated subpopulation of satellite cells. |
| Q33661107 | EF1alpha and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells |
| Q34205540 | Efficient in vitro myogenic reprogramming of human primary mesenchymal stem cells and endothelial cells by Myf5. |
| Q36670780 | Engraftment of ES-Derived Myogenic Progenitors in a Severe Mouse Model of Muscular Dystrophy |
| Q39516901 | Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin |
| Q38321965 | Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes. |
| Q48223753 | Hydrogel biomaterials and their therapeutic potential for muscle injuries and muscular dystrophies |
| Q59128593 | Induction of bone marrow-derived cells myogenic identity by their interactions with the satellite cell niche |
| Q33736192 | Influence of immune responses in gene/stem cell therapies for muscular dystrophies |
| Q47147004 | Insulin-Like Growth Factor Binding Protein-6 Alters Skeletal Muscle Differentiation of Human Mesenchymal Stem Cells |
| Q40508379 | Mechanical derivation of functional myotubes from adipose-derived stem cells. |
| Q36293152 | Mesenchymal stem cells and myoblast differentiation under HGF and IGF-1 stimulation for 3D skeletal muscle tissue engineering |
| Q36508661 | Mesenchymal stem cells: potential application in intervertebral disc regeneration. |
| Q88046702 | Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies |
| Q41136531 | Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation |
| Q26798810 | Potential of adipose-derived stem cells in muscular regenerative therapies |
| Q38079633 | Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies |
| Q33559684 | Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells |
| Q47630169 | Spontaneous and specific myogenic differentiation of human mesenchymal stem cells on polyethylene glycol-linked multi-walled carbon nanotube films for skeletal muscle engineering |
| Q99568694 | Stem cell therapy for muscular dystrophies |
| Q33902416 | Stem cell transplantation for muscular dystrophy: the challenge of immune response |
| Q44949025 | Systemic delivery of human mesenchymal stromal cells combined with IGF-1 enhances muscle functional recovery in LAMA2 dy/2j dystrophic mice |
| Q36676324 | The emerging biology of muscle stem cells: implications for cell-based therapies. |
| Q38167702 | Tissue engineering and regenerative medicine approaches to enhance the functional response to skeletal muscle injury |
| Q59001351 | Translational Research in Stem Cell Treatment of Neuromuscular Diseases |
| Q30542052 | Transplantated mesenchymal stem cells derived from embryonic stem cells promote muscle regeneration and accelerate functional recovery of injured skeletal muscle |
| Q34992272 | Vessel-associated stem cells from skeletal muscle: From biology to future uses in cell therapy |
| Q54906829 | MSCB9-Pax3 | described by source | P1343 |
Search more.